D. Loughney

发表

Approaches for machine learning intermolecular interaction energies and application to energy components from symmetry adapted perturbation theory.

Stephen R. Johnson, Brian L. Claus, Steven A. Spronk, 2020, The Journal of chemical physics.

Computer-assisted design and synthesis of novel aldose reductase inhibitors.

A. Treasurywala, J. Sredy, D. Loughney, 1989, Journal of medicinal chemistry.

Tryptamine and homotryptamine-based sulfonamides as potent and selective inhibitors of 15-lipoxygenase.

J. Macor, N. Murugesan, Z. Gu, 2005, Bioorganic & medicinal chemistry letters.

Phosphatase inhibitors--III. Benzylaminophosphonic acids as potent inhibitors of human prostatic acid phosphatase.

D. Loughney, S. Beers, E. Malloy, 1996, Bioorganic & medicinal chemistry.

HMG-CoA reductase inhibitors: design, synthesis, and biological activity of tetrahydroindazole-substituted 3,5-dihydroxy-6-heptenoic acid sodium salts.

P. Connolly, D. Loughney, L. Minor, 1993, Journal of medicinal chemistry.

Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP1.

L S Mulcahy, I. Wilson, O. Livnah, 1998, Biochemistry.

Novel thieno[2,3-b]- and [3,4-b]pyrans as potassium channel openers. Thiophene systems--XVII.

R. Falotico, D. Loughney, B. Haertlein, 1993, Bioorganic & medicinal chemistry.

Trends in kinase selectivity: insights for target class-focused library screening.

Stephen R. Johnson, Stephen R Johnson, Wayne Vaccaro, 2011, Journal of medicinal chemistry.

Collaborating to improve the use of free-energy and other quantitative methods in drug discovery

Herman van Vlijmen, Richard Lewis, Deborah A. Loughney, 2016, Journal of Computer-Aided Molecular Design.

A comparison of progestin and androgen receptor binding using the CoMFA technique

Deborah A. Loughney, Charles F. Schwender, D. Loughney, 1992, J. Comput. Aided Mol. Des..